Open-house discount agreements 2025-07

Summary

The health insurance funds HEK and/or hkk are seeking open-house discount agreements with pharmaceutical companies for the active substances, combinations, dosage forms, strengths or finished medicinal products specified in each lot. Unless a contract provides otherwise, the agreements cover all substitutable finished medicinal products supplied by the contracting pharmaceutical company. The terms are standardised, there are no individual negotiations or exclusive arrangements, and companies may join during the contract period, which ends no later than 31 July 2027.